Digital Health Record
Electronic health record AI governance for interoperability and data integrity.
HL7 FHIR, HIPAA, EHDS, Cures Act■ 9 diagnostic packs · 151 questions
Healthcare AI carries life-or-death stakes. AMC diagnostics probe whether your agent handles patient data correctly, follows clinical protocols, and responds safely under uncertainty.
Electronic health record AI governance for interoperability and data integrity. Frameworks: HL7 FHIR, HIPAA, EHDS, Cures Act.
Mental health and wellbeing AI governance for sensitive personal data. Frameworks: GDPR Art. 9, SAMHSA, ADA, ISO 45001.
Patient journey AI from admission through treatment and discharge. Frameworks: FDA 510(k), JCI, CMS, ISO 13131.
Clinical decision support and treatment recommendation AI safety. Frameworks: FDA 21 CFR 820, EU MDR, ICH GCP.
Healthcare professional AI tools governance and ethical standards. Frameworks: HIPAA, HITECH, ONC, AMA CPT.
AI-powered medical devices and in-vitro diagnostic governance. Frameworks: EU IVDR, FDA AI/ML SaMD, IEC 62304.
AI governance for computational chemistry, target identification, and trial design. Frameworks: FDA IND, ICH Q8-Q12, GxP, 21 CFR 11.
AI in clinical trial design, patient recruitment, and data management. Frameworks: ICH E6(R2) GCP, FDA 21 CFR 312.
Orphan drugs, pharmacogenomics, and rare disease AI governance. Frameworks: Orphan drugs, pharmacogenomics, WHO.
■ diagnostic packs
Electronic health record AI governance for interoperability and data integrity.
HL7 FHIR, HIPAA, EHDS, Cures ActMental health and wellbeing AI governance for sensitive personal data.
GDPR Art. 9, SAMHSA, ADA, ISO 45001Patient journey AI from admission through treatment and discharge.
FDA 510(k), JCI, CMS, ISO 13131Clinical decision support and treatment recommendation AI safety.
FDA 21 CFR 820, EU MDR, ICH GCPHealthcare professional AI tools governance and ethical standards.
HIPAA, HITECH, ONC, AMA CPTAI-powered medical devices and in-vitro diagnostic governance.
EU IVDR, FDA AI/ML SaMD, IEC 62304AI governance for computational chemistry, target identification, and trial design.
FDA IND, ICH Q8-Q12, GxP, 21 CFR 11AI in clinical trial design, patient recruitment, and data management.
ICH E6(R2) GCP, FDA 21 CFR 312Orphan drugs, pharmacogenomics, and rare disease AI governance.
Orphan drugs, pharmacogenomics, WHO